Rapidly Progressive Myasthenia Gravis with Pyramidal Tract Damage and Nystagmus:Clinical Analysis of One Case
1.Xuanwu Hospital Capital Medical University,Beijing 100053,China
2.Liuzhou General Hospital,Liuzhou 545006,China
3.Huanghua Development Zone Boai Hospital,Huanghua 061100,China
*Corresponding author:DA Yuwei,Professor,Doctoral supervisor,Chief physician;E-mail:dayuwei1000@163.com
WENG Yinhong,DA Yuwei,XU Min, et al. Rapidly Progressive Myasthenia Gravis with Pyramidal Tract Damage and Nystagmus:Clinical Analysis of One Case [J]. Chinese General Practice, 2019, 22(30): 3757-3761. DOI: 10.12114/j.issn.1007-9572.2019.00.115.
翁映虹,笪宇威,徐敏等. 伴锥体束损害及眼震快速进展型重症肌无力一例临床分析[J]. 中国全科医学, 2019, 22(30): 3757-3761. DOI: 10.12114/j.issn.1007-9572.2019.00.115.
[1]HEWETT K,SANDERS D B,GROVE R A.Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis[J].Neurology,2018,90(16):e1425-1434.DOI:10.1212/WNL.0000000000005323
[2]中华医学会神经病学分会神经免疫学组,中国免疫学会神经免疫学分会.中国重症肌无力诊断和治疗指南2015[J].中华神经科杂志,2015,48(11):934-940.DOI:10.3760/cma.j.issn.1006-7876.2015.11.002.
[3]WOLF Z,VERNAU K,SAFRA N,et al.Association of early onset myasthenia gravis in Newfoundland dogs with the canine major histocompatibility complex classⅠ[J].Neuromuscul Disord,2017,27(5):409-416.DOI:10.1016/j.nmd.2017.01.020.
[4]SANDERS D B,WOLFE G I,BENATAR M,et al.International consensus guidance for management of myasthenia gravis:executive summary[J].Neurology,2016,87(4):419-425.DOI:10.1212/WNL.0000000000003572.
[5]DEENEN J C,HORLINGS C G,VERSCHUUREN J J,et al.The epidemiology of neuromuscular disorders:a comprehensive overview of the literature[J].J Neuromuscul Dis,2015,2(1):73-85.
[6]OLIVEIRA E F,NACIF S R,PEREIRA N A,et al.Sleep disorders in patients with myasthenia gravis:a systematic,review[J].Sleep Science,2015,8(4):240-240.DOI:10.1016/j.slsci.2016.02.144.
[7]MAO Z,YIN J,LU Z,et al.Association between myasthenia gravis and cognitive function:a systematic review and meta-analysis[J].Ann Indian Acad Neurol,2015,18(2):131-137.DOI:10.4103/0972-2327.156560.
[8]DIAS-TOSTA E,KUCKEIHAUS G S,AMARAL K.Myasthenia gravis and peripheral neuropathy in an Amazon indigenous female[J].Neuromuscul Disord,1999,9(4):262-263.
[9]VERNINO S,ADAMSKI J,KRYZER T J,et al.Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes[J].Neurology,1998,50(6):1806-1813.DOI:10.1212/WNL.50.6.1806.
[10]DRACHMAN D B.Autonomic "myasthenia":the case for an autoimmune pathogenesis[J].J Clin Invest,2003,111(6):797-799.DOI:10.1172/JCI18180.
[11]SHARMA P,SHUKLA R,JAIN A,et al.Myasthenia gravis and reversible pyramidal tract signs in a thyrotoxic patient[J].Postgrad Med J,1991,67(788):590-591.DOI:10.1136/pgmj.67.788.590-a.
[12]张华,许贤豪,国红,等.重症肌无力全身表现及发病机制探讨[J].中华内科杂志,1997,36(6):368-371.
ZHANG H,XU X H,GUO H,et al.Systemic manifestations of myasthenia gravis and its putative pathogenesis[J].Chin J Intern Med,1997,36(6):368-371.
[13]欧阳宛炯.双侧锥体束征阳性的重症肌无力1例报道[J].卒中与神经疾病,2010,17(4):246.DOI:10.3969/j.issn.1007-0478.2010.04.016.
OUYANG W J.Myasthenia gravis with positive bilateral pyramidal tract sign:a case report[J].Stroke and Nervous Diseases,2010,17(4):246.DOI:10.3969/j.issn.1007-0478.2010.04.016.
[14]庞英,宿英英.重症肌无力伴锥体束征一例报告[J].中国神经免疫学和神经病学杂志,2005,12(4):238.DOI:10.3969/j.issn.1006-2963.2005.04.018.
PANG Y,SU Y Y.Myasthenia gravis with pyramidal tract sign:a case report[J].Chin J Neuroimmunol Neurol,2005,12(4):238.DOI:10.3969/j.issn.1006-2963.2005.04.018.
[15]MüLLER K M,TASKINEN E,LEFVERT A K,et al.Immunoactivation in the central nervous system in myasthenia gravis[J].J Neurol Sci,1987,80(1):13-23.DOI:10.1016/0022-510X(87)90217-6.
[16]NIJSSE B,BETTINK M W,NEUTEBOOM R F.Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis[J].BMJ Case Rep,2014,2014:2013203234.DOI:10.1136/bcr-2013-203234.
[17]ACERS T E.Ocular myasthenia gravis mimicking pseudointernuclear ophthalmoplegia and variable esotropia[J].Am J Ophthalmol,1979,88(3 Pt 1):319-321.DOI:10.1016/0002-9394(79)90627-5.
[18]ITO K,MIZUTANI J,MUROFUSHI T,et al.Bilateral pseudo-internuclear ophthalmoplegia in myasthenia gravis[J].ORL,1997,59(2):122-126.DOI:10.1159/000276922.
[19]KHANNA S,LIAO K,KAMINSKI H J,et al.Ocular myasthenia revisited:insights from pseudo-internuclear ophthalmoplegia[J].Journal of Neurology,2007,254(11):1569-1574.DOI:10.1007/s00415-007-0591-y.
[20]林书乐,翁其彪.眼肌型重症肌无力合并眼球震颤二例报告[J].南方医科大学学报,1990,10(2):138.
LIN S L,WENG Q B.Ocular myasthenia gravis combined with nystagmus:two cases report[J].J South Med Univ,1990,10(2):138.
[21]LEFVERT A K,PIRSKANEN R.Acetylcholine-receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis[J].Lancet,1977,310(8033):351-352.DOI:10.1016/S0140-6736(77)91506-9.
[22]BERGONZI P,MAZZA S,MENNUI G,et al.Central nervous system involvement in myasthenia gravis[J].Annals of the New York Academy of Sciences,2010,377(1):810-811.DOI:10.1111/j.1749-6632.1981.tb33780.x.
[23]李柱一,丘晓飞,鞠躬,等.重症肌无力中枢神经系统受损模型[J].中华神经科杂志,1997,30(4):218-222.
LI Z Y,QIU X F,JU G,et al.A novel model of central nervous system involvement in myasthenia gravis[J].Chin J Neurol,1997,30(4):218-222.
[24]GILHUS N E,VERSCHUUREN J J.Myasthenia gravis:subgroup classification and therapeutic strategies[J].Lancet Neurology,2015,14(10):1023-1036.DOI:10.1016/S1474-4422(15)00145-3.